Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ru Ju Wang

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Zhongguo Shi Yan Xue Ye Xue Za Zhi|December 11, 2021
[Interpretation of ASTCT Consensus Responses by Chimeric Antigen Receptor T Cell Therapy CRS/ICANS--Review]Cheng-Cheng Fu, Ru-Ju Wang, De-Pei Wu
Science (New York, N.Y.)|March 10, 2007
Super plastic bulk metallic glasses at room temperatureYan Hui Liu, Gang Wang, Ru Ju Wang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|September 11, 2025
[PD-1 Inhibitor Combined with Azacitidine and HAG Regimen for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia: A Prospective, Single-Arm, Phase II Clinical Study]Cheng-Sen Cai, Ru-Ju Wang, Xiao-Yan Xu, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Zhongguo Shi Yan Xue Ye Xue Za Zhi|December 11, 2021
[Interpretation of ASTCT Consensus Responses by Chimeric Antigen Receptor T Cell Therapy CRS/ICANS--Review]Cheng-Cheng Fu, Ru-Ju Wang, De-Pei Wu
Science (New York, N.Y.)|March 10, 2007
Super plastic bulk metallic glasses at room temperatureYan Hui Liu, Gang Wang, Ru Ju Wang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|September 11, 2025
[PD-1 Inhibitor Combined with Azacitidine and HAG Regimen for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia: A Prospective, Single-Arm, Phase II Clinical Study]Cheng-Sen Cai, Ru-Ju Wang, Xiao-Yan Xu, et al.
Pageof 1